MedPath

DIPROLENE

These highlights do not include all the information needed to use DIPROLENE Ointment safely and effectively. See full prescribing information for DIPROLENE Ointment. DIPROLENE (augmented betamethasone dipropionate) ointment, for topical useInitial U.S. Approval: 1983

Approved
Approval ID

0b9543ad-2ca7-430d-aef9-81c376dc2e6c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 23, 2022

Manufacturers
FDA

Organon LLC

DUNS: 117494753

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

betamethasone dipropionate

PRODUCT DETAILS

NDC Product Code78206-124
Application NumberNDA018741
Marketing CategoryC73594
Route of AdministrationTOPICAL
Effective DateFebruary 23, 2022
Generic Namebetamethasone dipropionate

INGREDIENTS (5)

BETAMETHASONE DIPROPIONATEActive
Quantity: 0.5 mg in 1 g
Code: 826Y60901U
Classification: ACTIM
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
PROPYLENE GLYCOL MONOPALMITOSTEARATEInactive
Code: F76354LMGR
Classification: IACT
WHITE WAXInactive
Code: 7G1J5DA97F
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.